JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 153 filers reported holding JUNO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 2.17 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $84,601,000 | +30.0% | 1,850,820 | +27.6% | 2.01% | +56.9% |
| Q3 2017 | $65,074,000 | +1798.3% | 1,450,607 | +1164.8% | 1.28% | +1290.2% |
| Q2 2017 | $3,428,000 | +34.7% | 114,695 | 0.0% | 0.09% | +43.8% |
| Q1 2017 | $2,545,000 | +12.8% | 114,695 | -4.2% | 0.06% | 0.0% |
| Q4 2016 | $2,256,000 | -93.3% | 119,668 | -89.4% | 0.06% | -93.5% |
| Q3 2016 | $33,740,000 | +409.2% | 1,124,285 | +646.1% | 0.99% | +391.5% |
| Q4 2015 | $6,626,000 | +121.2% | 150,684 | +104.6% | 0.20% | +139.3% |
| Q3 2015 | $2,996,000 | -52.8% | 73,631 | -38.1% | 0.08% | -47.8% |
| Q2 2015 | $6,344,000 | -79.2% | 118,954 | -76.9% | 0.16% | -80.9% |
| Q1 2015 | $30,488,000 | -7.5% | 514,585 | -18.5% | 0.84% | +9.2% |
| Q4 2014 | $32,953,000 | – | 631,042 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|